Renal Cancer - Results from #2520

Safety and Oncologic Outcomes of Magnetic Resonance Imaging-Guided Cryoablation of Renal Cell Carcinoma: A 10-Year Single-Center Experience. September 10, 2020

Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma. September 10, 2020

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial. September 10, 2020

Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy. September 9, 2020

A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma. September 9, 2020

Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a real-world setting. September 9, 2020

Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis. September 8, 2020

Robotic-assisted partial nephrectomy (RAPN) and standardization of outcome reporting: a prospective, observational study on reaching the "Trifecta and Pentafecta". September 8, 2020

A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma. September 8, 2020

Combination drug regimens for metastatic clear cell renal cell carcinoma. September 7, 2020

A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma. September 7, 2020

Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer. September 7, 2020

The clinical significance of routine risk categorization in metastatic renal cell carcinoma and its impact on treatment decision-making: a systematic review. September 4, 2020

Avelumab and axitinib combination therapy for the treatment of advanced renal cell carcinoma. September 4, 2020

Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population. September 4, 2020

Second-line tyrosine kinase inhibitor-therapy after immunotherapy-failure. September 3, 2020

Percutaneous microwave ablation of renal masses in a UK cohort. September 3, 2020

Renal cell carcinoma: The role of radical surgery on different patterns of local or distant recurrence. September 2, 2020

Neutrophil-to-mean platelet volume ratio as a new predictor for overall and cancer-specific survival in patients with localized clear cell renal cell carcinoma. September 2, 2020

Diagnostic accuracy and safety of percutaneous MRI-guided biopsy of solid renal masses: single-center results after 4.5 years. September 2, 2020

Page 127 of 456